After encouraging early studies, they have now landed a patent for their methods.
Dr. David Ahlquist, a Mayo Clinic medical professor and consultant in its division of gastroenterology and hepatology, led the team that, late in the last decade, developed the genomic science behind the Cologuard test, which Mayo licensed in 2009 to Exact Sciences Corp. (NASDAQ: EXAS) of Madison, Wisconsin. Read more . . .